High Prevalence of Multidrug-Resistant Bacteria in Libyan War Casualties Admitted to a Tertiary Care Hospital,

Benedikt Lohr1, Yvonne Pfeifer2, Ursel Heudorf3

  • 11 Institute for Laboratory Medicine , Microbiology & Infection Control, Northwest Medical Centre, Frankfurt/Main, Germany .

Microbial Drug Resistance (Larchmont, N.Y.)
|October 18, 2017
PubMed

Insights

Libyan war casualties admitted to Germany had a high rate of multidrug-resistant organisms (MDROs), including carbapenem-resistant gram-negative organisms (CROs) and methicillin-resistant Staphylococcus aureus (MRSA). This highlights the risk of cross-border infectious disease transmission.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • The Libyan conflict poses a significant risk for the cross-border spread of multidrug-resistant organisms (MDROs).
  • War casualties are vulnerable to infections, and their transfer can introduce resistant pathogens into new healthcare settings.

Purpose of the Study:

  • To assess the prevalence of MDROs in Libyan war casualties treated in Germany.
  • To identify specific MDROs and their resistance mechanisms.

Main Methods:

  • Screening of 67 Libyan war casualties admitted to a German medical center from August 2016 to January 2017.
  • Molecular detection of resistance genes (e.g., β-lactamases, quinolone resistance genes) in identified MDROs.
  • Bacterial strain typing using enzymatic macrorestriction and pulsed-field gel electrophoresis.

Main Results:

  • MDROs were detected in 60% of patients (40/67).
  • Carbapenem-resistant gram-negative organisms (CROs) were found in 37% (25/67), and methicillin-resistant Staphylococcus aureus (MRSA) in 16% (11/67).
  • Common carbapenemases included NDM, OXA-48, and OXA-23, alongside other β-lactamases and quinolone resistance genes. Various bacterial clones were identified.

Conclusions:

  • Libyan war casualties carry a substantial burden of MDROs, posing a significant public health risk.
  • Effective screening and containment strategies are crucial for healthcare institutions receiving such patients to prevent onward transmission.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...